Trending...
- How to Apply Online for a Loan that pays You in 24 hours
- All Traffic Data, a Seaport Capital Portfolio Company, Acquires Traffic Survey Specialists
- The New Trace One Ushers in a New Era for CPG and Retail Product Innovation
BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that Scott Hutton, Chief Executive Officer of Biodesix, will present and host in-person 1x1 investor meetings at William Blair's 43rd Annual Growth Stock Conference, which will be held from June 6-8, 2023.
William Blair's 43rd Annual Growth Stock Conference
Presentation Date: Wednesday, June 7, 2023
Presentation Time: 4:40 PM CT
Location: Loews Chicago Hotel, Chicago, IL
The presentation will be webcast live and available for replay under "News & Events" in the Investors section of Biodesix's website at Biodesix.com.
About Biodesix
Biodesix is a leading data-driven diagnostic solutions company with a focus in lung disease. The Company develops diagnostic tests addressing important clinical questions by combining multi-omics through the power of artificial intelligence. Biodesix offers five Medicare-covered tests for patients with lung diseases. The blood based Nodify Lung® nodule risk assessment testing strategy, consisting of the Nodify XL2® and the Nodify CDT® tests, evaluates the risk of malignancy in pulmonary nodules, enabling physicians to better triage patients to the most appropriate course of action. The blood based IQLung™ strategy for lung cancer patients integrates the GeneStrat® targeted ddPCR™ test, the GeneStrat NGS™ test and the VeriStrat® test to support treatment decisions across all stages of lung cancer with results in an average of two to three business days, expediting time to treatment. Biodesix also leverages the proprietary and advanced Diagnostic Cortex® AI (Artificial Intelligence) platform, to collaborate with many of the world's leading biotechnology and pharmaceutical companies to solve complex diagnostic challenges in lung disease. For more information about Biodesix, visit biodesix.com.
More on Colorado Desk
Note Regarding Forward-Looking Statements
This press release may contain forward-looking statements that involve substantial risks and uncertainties for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. All statements contained in this press release other than statements of historical fact, are forward-looking statements. The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "plan," "expect," "predict," "potential," "opportunity," "goals," or "should," and similar expressions are intended to identify forward-looking statements. Such statements are based on management's current expectations and involve risks and uncertainties. Actual results and performance could differ materially from those projected in the forward-looking statements as a result of many factors. Biodesix has based these forward-looking statements largely on its current expectations and projections about future events and trends. These forward-looking statements are subject to a number of risks, uncertainties, and assumptions. Forward-looking statements may include information concerning the impact of the COVID-19 pandemic on Biodesix and its operations, its possible or assumed future results of operations, including descriptions of its revenues, profitability, outlook, and overall business strategy. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. The Company's ability to continue as a going concern could cause actual results to differ materially from those contemplated in this press release and additionally, other factors that could cause actual results to differ materially from those contemplated in this press release can be found in the Risk Factors section of Biodesix's most recent annual report on Form 10-K, filed March 14, 2022 or subsequent quarterly reports on Form 10-Q during 2022, if applicable. Biodesix undertakes no obligation to revise or publicly release the results of any revision to such forward-looking statements, except as required by law. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. All forward-looking statements are qualified in their entirety by this cautionary statement.
More on Colorado Desk
Contacts
Media:
Robbie Lunt
robbie.lunt@biodesix.com
1-866-432-5930
Investors:
Chris Brinzey
chris.brinzey@westwicke.com
1-339-970-2843
William Blair's 43rd Annual Growth Stock Conference
Presentation Date: Wednesday, June 7, 2023
Presentation Time: 4:40 PM CT
Location: Loews Chicago Hotel, Chicago, IL
The presentation will be webcast live and available for replay under "News & Events" in the Investors section of Biodesix's website at Biodesix.com.
About Biodesix
Biodesix is a leading data-driven diagnostic solutions company with a focus in lung disease. The Company develops diagnostic tests addressing important clinical questions by combining multi-omics through the power of artificial intelligence. Biodesix offers five Medicare-covered tests for patients with lung diseases. The blood based Nodify Lung® nodule risk assessment testing strategy, consisting of the Nodify XL2® and the Nodify CDT® tests, evaluates the risk of malignancy in pulmonary nodules, enabling physicians to better triage patients to the most appropriate course of action. The blood based IQLung™ strategy for lung cancer patients integrates the GeneStrat® targeted ddPCR™ test, the GeneStrat NGS™ test and the VeriStrat® test to support treatment decisions across all stages of lung cancer with results in an average of two to three business days, expediting time to treatment. Biodesix also leverages the proprietary and advanced Diagnostic Cortex® AI (Artificial Intelligence) platform, to collaborate with many of the world's leading biotechnology and pharmaceutical companies to solve complex diagnostic challenges in lung disease. For more information about Biodesix, visit biodesix.com.
More on Colorado Desk
- NEOM and Maysalward to strengthen young gaming talent with launch of NEOM Game Dev Challenge
- Colorado Governor Jared Polis Releases Statement Following News That The House and Senate Reached an Agreement on a Temporary Funding Measure to Avoid Federal Government Shutdown
- Governor Polis Orders Flags to be Lowered to Honor Colorado Springs Community Parole Officer Christine Guerin Sandoval
- Colorado: Gov. Polis and Gov. Cox Release Joint Statement Urging for Federal Government to Prevent Shutdown
- Jeezy, Sexyy Red, Plies, And $hyfromdatre Support The HBCU Community With A Special Concert For NC College Students In Winston-Salem, NC on Oct. 27th
Note Regarding Forward-Looking Statements
This press release may contain forward-looking statements that involve substantial risks and uncertainties for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. All statements contained in this press release other than statements of historical fact, are forward-looking statements. The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "plan," "expect," "predict," "potential," "opportunity," "goals," or "should," and similar expressions are intended to identify forward-looking statements. Such statements are based on management's current expectations and involve risks and uncertainties. Actual results and performance could differ materially from those projected in the forward-looking statements as a result of many factors. Biodesix has based these forward-looking statements largely on its current expectations and projections about future events and trends. These forward-looking statements are subject to a number of risks, uncertainties, and assumptions. Forward-looking statements may include information concerning the impact of the COVID-19 pandemic on Biodesix and its operations, its possible or assumed future results of operations, including descriptions of its revenues, profitability, outlook, and overall business strategy. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. The Company's ability to continue as a going concern could cause actual results to differ materially from those contemplated in this press release and additionally, other factors that could cause actual results to differ materially from those contemplated in this press release can be found in the Risk Factors section of Biodesix's most recent annual report on Form 10-K, filed March 14, 2022 or subsequent quarterly reports on Form 10-Q during 2022, if applicable. Biodesix undertakes no obligation to revise or publicly release the results of any revision to such forward-looking statements, except as required by law. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. All forward-looking statements are qualified in their entirety by this cautionary statement.
More on Colorado Desk
- ACCU, Inc. Takes Community Association Management to New Heights with Revamped Webpage
- HILCO REAL ESTATE ANNOUNCES THE SALE OF 39,900± SF INDUSTRIAL WAREHOUSE IN DELTA, CO
- Global Luxury Value Exchange, Idoneus, Transitions to 100% IDON Transactions
- USA Green Card Celebrates the State Department's Historic Inclusion of the UK in the DV-2025 Green Card Lottery
- Colorado: Governor Polis Takes Action to Keep National Parks Open if a Federal Shutdown Occurs
Contacts
Media:
Robbie Lunt
robbie.lunt@biodesix.com
1-866-432-5930
Investors:
Chris Brinzey
chris.brinzey@westwicke.com
1-339-970-2843
Filed Under: Business
0 Comments
Latest on Colorado Desk
- Real Estate Investment Firm In Colorado Buys Houses With Squatters Inside
- High 5 Plumbing opens new headquarters in Golden
- Democratizing Water Monitoring with Open Source Floaters
- Sitio Royalties Prices Upsized $600 Million Offering of Senior Notes
- BOW RIVER CAPITAL SUPPORTS WAUD CAPITAL AND UNIFEYE VISION PARTNERS WITH ACQUISITION FINANCING
- Colorado: Governor Polis Releases Statement on Phil DiStefano
- Colorado Access Selects Owl to Advance Quality and Reduce Costs in Behavioral Healthcare
- The Luxe Team at Dale Sorensen Real Estate Brevard Presents 100 Ocean Condominium in Melbourne, Florida
- How to Apply Online for a Loan that pays You in 24 hours
- Metro Commercial Miami Team Doubles
- All Traffic Data, a Seaport Capital Portfolio Company, Acquires Traffic Survey Specialists
- Wave2 Launches New Dynamic Data Integration Features to Elevate Bank and Credit Union Convenience
- Texas Advocacy Project Aids 10k+ Abuse Victims Annually; Offers Subject Matter Experts for Domestic Violence Awareness Month
- Introducing Stack & Sprout: The Revolutionary Vertical Plant Growing System for Urban Gardeners
- Higi Selects ThoroughCare to Assist in Managing Chronically Ill Patients
- Callan Adds Constantine Braswell to Growing Private Credit Team
- Introducing the State-of-the-Art National Security Operations Center: Enhancing Safety and Vigilance Nationwide
- Zayo Supercharges Connectivity With Fully-Enabled 400G European Network
- August 2023 Financial Market Review
- NUBURU Strengthens Executive Management Team